- Lobbying
- ferring AND pharmaceuticals
Lobbying Arrangements Results for 'Ferring Pharmaceuticals'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details CMS Coding process |
Ferring Pharmaceuticals, Inc.
|
Connect 4 Strategies, LLC | |||
Details Health Care and pharmaceutical issues. |
FERRING PHARMACEUTICALS - USA
Pharmaceuticals |
BUCHANAN INGERSOLL & ROONEY PC | |||
Details Issues related to fertility treatment and coverage for federal employees (no bill); issues related to veteran health care coverage (no bill); H.R. 544, Veterans Infertility Treatment Act (entire bi... |
Ferring Pharmaceuticals
|
in-house lobbying | |||
Details Veterans Health Issues |
Ferring Pharmaceuticals, Inc.
|
The Michael Lewan Company | |||
Details Veterans healthcare benefits. |
Ferring Pharmaceuticals, Inc.
|
HillStaffer, LLC | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs associated with gene therapy and oncology treatments. |
Ferring Pharmaceuticals, Inc.
|
BAKER & HOSTETLER LLP | |||
Details Educating Congress related to fertility accessibility and care. |
Ferring Pharmaceuticals, Inc.
|
PILLSBURY WINTHROP SHAW PITTMAN LLP | |||
Details Pharmaceutical Issues |
Ferring Pharmaceuticals, Inc.
|
McGuireWoods Consulting (A Subsidiary of McGuireWoods LLP) | |||
Details Presenting the merits of reindeer herding and seeking support for World Bank funded projects to protect the livelihood of reindeer herders |
Ferring International Center SA
|
Cornerstone Government Affairs, Inc. | |||
Details Issues pertaining to reproductive health and access and coverage of infertility treatments and care as it relates to health equity. |
Ferring Pharmaceuticals
|
The Madison Group | |||
Details Access to in vitro fertilization therapeutics and procedures; antibiotic resistance NDAA; access to assisted reproductive technology |
Ferring Pharmaceuticals Inc.
|
Prime Policy Group | |||
Details Issues related to implementation of average sales price reporting requirements. Issues related to patient access. |
Ferring Pharmaceuticals, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues pertaining to reproductive health and access and coverage of infertility treatments and care. Issues related to infectious disease and hospital acquired infections. |
Ferring Pharmaceuticals Inc.
|
Todd Strategy Group | |||
Details issues related to microbiome, oncology, fertility, and health equity Issues related to formulary tier status NDAA FY24 |
Ferring Pharmaceuticals Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP |